CD4 and lung carcinoma: Conversely, individual cancer types (e.g., lung cancers) can diverge by forming distinct immune archetypes, ranging from osteoclast-mediated niches to environments enriched with immunosuppressive CD4+ regulatory T cells and exhausted CD8+ T cells, underscoring the complex interplay between tumor origin and immune microenvironment adaptations [35].